282 related articles for article (PubMed ID: 12738392)
21. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
22. Immunization with the immunodominant Helicobacter suis urease subunit B induces partial protection against H. suis infection in a mouse model.
Vermoote M; Van Steendam K; Flahou B; Smet A; Pasmans F; Glibert P; Ducatelle R; Deforce D; Haesebrouck F
Vet Res; 2012 Oct; 43(1):72. PubMed ID: 23101660
[TBL] [Abstract][Full Text] [Related]
23. Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
Jiang W; Baker HJ; Smith BF
Infect Immun; 2003 Jan; 71(1):40-6. PubMed ID: 12496147
[TBL] [Abstract][Full Text] [Related]
24. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
Lü L; Cao HD; Zeng HQ; Wang PL; Wang LJ; Liu SN; Xiang TX
Vaccine; 2009 Feb; 27(7):972-8. PubMed ID: 19111590
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
[TBL] [Abstract][Full Text] [Related]
26. Protection Against
Pan X; Ke H; Niu X; Li S; Lv J; Pan L
Front Immunol; 2018; 9():1003. PubMed ID: 29867978
[TBL] [Abstract][Full Text] [Related]
27. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
[TBL] [Abstract][Full Text] [Related]
28. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
[TBL] [Abstract][Full Text] [Related]
29. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
30. Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.
Nedrud JG; Bagheri N; Schön K; Xin W; Bergroth H; Eliasson DG; Lycke NY
PLoS One; 2013; 8(12):e83321. PubMed ID: 24391754
[TBL] [Abstract][Full Text] [Related]
31. Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine.
O'Riordan AA; Morales VA; Mulligan L; Faheem N; Windle HJ; Kelleher DP
Vaccine; 2012 Jun; 30(26):3876-84. PubMed ID: 22512976
[TBL] [Abstract][Full Text] [Related]
32. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
33. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori vaccine: mucosal adjuvant & delivery systems.
Sijun H; Yong X
Indian J Med Res; 2009 Aug; 130(2):115-24. PubMed ID: 19797807
[TBL] [Abstract][Full Text] [Related]
35. Outer membrane vesicles from genetically engineered
Liu Q; Shang Y; Shen L; Yu X; Cao Y; Zeng L; Zhang H; Rao Z; Li Y; Tao Z; Liu Z; Huang X
Virulence; 2024 Dec; 15(1):2367783. PubMed ID: 38937901
[TBL] [Abstract][Full Text] [Related]
36. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
[TBL] [Abstract][Full Text] [Related]
37. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.
Skene CD; Doidge C; Sutton P
Vaccine; 2008 Jul; 26(31):3880-4. PubMed ID: 18547687
[TBL] [Abstract][Full Text] [Related]
39. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
[TBL] [Abstract][Full Text] [Related]
40. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model.
Andrew DW; Hafner LM; Beagley KW; Timms P
J Reprod Immunol; 2011 Sep; 91(1-2):9-16. PubMed ID: 21856018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
